Marc E. Lippman

Georgetown University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

108h-index41.4kcitations600works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(173), HER2/EGFR in Cancer Research(73), Breast Cancer Treatment Studies(72), Cancer Cells and Metastasis(59), Cancer Treatment and Pharmacology(39)

Publications595 total

Abstract P1-04-19: Regulating Stress to Improve Antitumor Immunity in Breast Cancer Models
Clinical Cancer Research·2025
Abstract P1-06-07: APOE4 impairs the cardiac stress response to doxorubicin through defective M2 macrophage activation and tissue repair transcription pathways
Clinical Cancer Research·2025
RAC1 Regulates Shh-Medulloblastoma Growth via GLI-Mediated Transcription
2025Open Access
RAGE inhibition to decrease cancer therapy related cardiotoxicity in women with early breast cancer (RAGE).
Journal of Clinical Oncology·2024
RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer
npj Breast Cancer·2023· 33 citedOpen Access
Supplemental Figure 1 from Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch
2023Open Access
Figure S3 from Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and Survival
2023Open Access
Table S1 from RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer
2023Open Access
Figure S4 from Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and Survival
2023Open Access
Table S1 from RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer
2023Open Access
Figure S1 from Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and Survival
2023Open Access
Figure S5 from RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer
2023Open Access
Data from Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and Survival
2023Open Access
Figure S5 from Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and Survival
2023Open Access
Figure S4 from RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer
2023Open Access
Figure S3 from RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer
2023Open Access
Figure S2 from RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer
2023Open Access
Figure S1 from Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and Survival
2023Open Access
Figure S5 from RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer
2023Open Access
Supplemental Figure 2 from Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch
2023Open Access
page 1 of 30Next →

Frequent Co-authors

Robert B. Dickson(12), Karen Huff(5), David N. Danforth(5), Soonmyoung Paik(4), Seth M. Steinberg(4), Sandra M. Swain(4), Michael D. Johnson(3), Cornelius Knabbe(3), Attan Kasid(3), Bernard Fisher(3), Douglas Yee(3), Neal Rosen(3), E. Brad Thompson(3), Susan E. Bates(3), Mary E. McManaway(3), Diane Bronzert(3), Edward P. Gelmann(3), Stephen P. Ethier(2), Stephen Eckert(2), K A Krueger(2)